Literature DB >> 31656898

Ring-Fused Diphenylchlorins as Potent Photosensitizers for Photodynamic Therapy Applications: In Vitro Tumor Cell Biology and in Vivo Chick Embryo Chorioallantoic Membrane Studies.

Bruno F O Nascimento1, Mafalda Laranjo2,2, Nelson A M Pereira1, João Dias-Ferreira2, Marta Piñeiro1, Maria Filomena Botelho2,2, Teresa M V D Pinho E Melo1.   

Abstract

Ring-fused diphenylchlorins as potent low-dose photosensitizers for photodynamic therapy of bladder carcinoma and esophageal adenocarcinoma are described. All studied molecules were very active against HT1376 urinary bladder carcinoma and OE19 esophageal adenocarcinoma cell lines, showing IC50 values below 50 nM. The in vivo evaluation of the more promising photosensitizer, using an OE19 tumor/chick embryo chorioallantoic membrane model, showed a tumor weight regression of 33% with a single photodynamic therapy treatment with the photosensitizer dose as low as 37 ng/embryo.
Copyright © 2019 American Chemical Society.

Entities:  

Year:  2019        PMID: 31656898      PMCID: PMC6811853          DOI: 10.1021/acsomega.9b01865

Source DB:  PubMed          Journal:  ACS Omega        ISSN: 2470-1343


Introduction

Photodynamic therapy (PDT) has been used in the treatment of several types of cancers[1−8] and also in other diseases, such as actinic keratosis,[9−11] acne,[12,13] Barrett’s esophagus,[14,15] and age-related macular degeneration (AMD).[16,17] PDT is based on the administration of a photosensitizer (PS), which selectively locates itself in the tumor cells followed by visible light irradiation. Suitable light exposure of the tumor region leads to the formation of cytotoxic reactive oxygen species (ROS), for example, hydroxyl radicals, the superoxide anion, and singlet oxygen, that induce cell death. These features provide PDT with an interesting and much valued dual selectivity.[18] Photosensitizer molecules should be activated with light of 600 to 800 nm wavelengths, the phototherapeutic window, which bears enough energy to produce ROS, can reach deeper into the tissues and avoid excitation of endogenous chromophores.[19,20] Therefore, one of the desirable characteristics of the photosensitizer is to absorb strongly within this range. In fact, the most efficient porphyrin-derived PSs are chlorins, hydroporphyrins that present typically intense absorption bands in the red and near-infrared (NIR) regions. Among these, either currently approved or in clinical trials, chlorins Foscan,[22−25] Verteporfin,[26,27] and Radachlorin[28,29] stand out. The synthetic strategies for the preparation of chlorins have been centered on modifications of naturally occurring chlorins, total synthesis, and transformation of porphyrins via reduction, cycloaddition, and annulation reactions[20,30−34] with the most common one being based on Whitlock’s method of porphyrin reduction with diimide.[35] However, this methodology affords chlorins with limited stability due to the easy reoxidation to the porphyrin state and leads to the formation of by-products, for example, other hydroporphyrins, making the purification process extremely difficult in some cases. Our contribution overcame this with the development of a new class of highly stable ring-fused chlorins. Novel 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine-fused chlorins were synthesized via [8π + 2π] cycloaddition of transient 1,7-dipole diazafulvenium methides with porphyrins.[36,37] Further studies demonstrated that this kind of ring-fused meso-tetraphenylchlorins, particularly a new dihydroxymethyl derivative, has an impressive performance against human skin malignant melanoma.[38] Furthermore, the incorporation of the platinum(II) metal into their structure originated excellent theranostic agents for imaging, PDT, and molecular oxygen sensing.[39] Our contribution to PDT of melanoma extended to the study of novel ring-fused 5,15-diphenylchlorins (Figure . These chlorins were even more photocytotoxic against A375 skin malignant melanoma cells than the corresponding tetraphenyl analogues, presenting IC50 values as low as 2.9 nM.[40] Furthermore, for one of the derivatives (chlorin 3), the cell death outcome, apoptosis versus necrosis, was determined by its concentration. This can be explored to control the type of cell death in order to improve the effectiveness of PDT considering that an inflammatory response resulting from necrotic cell death after PDT can activate the antitumor immune response with implications also on vascular damage.[20,21] This feature combined with very low dark cytotoxicity makes chlorin 3 a particular interesting photosensitizer for PDT.
Figure 1

Chemical structures, UV–vis absorption spectra, and IC50 values against A375 melanoma cells of chlorins 1–4.[40]

Chemical structures, UV–vis absorption spectra, and IC50 values against A375 melanoma cells of chlorins 1–4.[40] These outstanding results led us to further explore chlorins 1–4 as PDT agents against other selected cancers. PDT has been proven beneficial to both esophageal and urinary bladder carcinomas due to easy endoscopic irradiation, representing an effective, powerful, and minimally invasive treatment option.[41,42] The use of PDT in these tumors offered long survival periods and even a cure for some patients.[43−46] To take a step forward and further examine the photosensitizing capabilities of these ring-fused diphenylchlorins, we decided to spread the scope of our research by carrying out early in vivo assessment of the more promising photosensitizer using the chick embryo chorioallantoic membrane (CAM) model. Although the use of PSs and their accomplishments concerning vascular development and angiogenesis,[47,48] tissular O2 measuring,[49,50] and cancer diagnostics[51,52] have been reported using this model, this is still a somewhat underutilized in vivo assay when it comes to cancer PDT.[53,54] Details on our latest work regarding the aforementioned topics are herein disclosed.

Results and Discussion

Ring-fused diphenylchlorins 1–4 were prepared and isolated following synthetic procedures established at our labs and previously described (Figure .[37,40] 5,15-Diphenylporphyrin was reacted with the diazafulvenium methide generated in situ from dimethyl 2,2-dioxo-1H,3H-pyrazolo[1,5-c][1,3]thiazole-6,7-dicarboxylate to afford the target 10,20-diphenylchlorins 1 and 2. The reduction of these diester chlorins (1 and 2) with lithium aluminum hydride led to the corresponding dihydroxymethyl chlorins (3 and 4).[37,40] Chlorins 1–4 present photophysical properties that are adequate to their use as photosensitizers with high absorption at the therapeutic window and moderate to high singlet oxygen quantum yields. The photocytotoxicity of ring-fused diphenylchlorins 1–4 against human HT1376 urinary bladder carcinoma and OE19 esophageal adenocarcinoma cell lines was investigated; the corresponding dose–response curves are presented in Figure , and related IC50/CI95 values are summarized in Table . PDT toxicity evaluation was carried out 24 h after irradiation (a fluence rate of 7.5 mW/cm2, total fluence of 10 J, and a filtered light source with a cutoff of <560 nm). Chlorins 1–4 showed high phototoxicity against bladder carcinoma cells with IC50 values between 12.8 and 43.0 nM. Photocytoxicity was also very high against esophageal adenocarcinoma cells with IC50 values below 26.6 nM. Therefore, chlorins 1–4 were demonstrated to be remarkably powerful low-dose photosensitizing agents showing IC50 values below 50 nM against all tumor cell lines studied.
Figure 2

Dose–response curves of HT1376 (above) and OE19 (below). Analysis was performed 24 h after PDT using chlorins 1–4 with energy of 10 J. Data points represent the mean ± SD.

Table 1

IC50 and Respective Confidence Intervals at 95% (CI95) of Chlorins 1–4 in HT1376 and OE19 Cellsa

 photocytotoxicity (nM)
 HT1376OE19
chlorinIC50CI95IC50CI95
133.6[26.7; 42.3]25.5[20.5; 34.7]
222.3[15.9; 31.4]14.1[8.4; 23.5]
343.0[33.0; 56.1]26.6[20.5; 34.7]
412.8[9.8; 16.6]12.9[11.1; 15.0]

Analysis was performed 24 h after PDT with energy of 10 J. Values were determined by dose–response sigmoidal fitting.

Dose–response curves of HT1376 (above) and OE19 (below). Analysis was performed 24 h after PDT using chlorins 1–4 with energy of 10 J. Data points represent the mean ± SD. Analysis was performed 24 h after PDT with energy of 10 J. Values were determined by dose–response sigmoidal fitting. 5,15-Diphenylchlorins either with exocyclic methyl ester or hydroxymethyl functionalities, 2 and 4, respectively, proved to be better photodynamic agents against both cell lines than 10,20-diphenylchlorins 1 and 3. There was a curious change regarding the previously reported results on the PDT activity of diphenylchlorins 1–4 against melanoma (A375 cells) where the more hydrophilic hydroxymethyl chlorins 3 and 4 were approximately 3 to 5 times more active than their equivalent methyl ester analogues 1 and 2.[40] A different structure–activity trend was observed with HT1376 and OE19 cells. Hence, in addition to the overall hydrophilic/hydrophobic nature of the diphenylchlorin scaffold, it appears that the diphenyl substitution pattern of the macrocycle, 5,15-diphenylchlorins versus 10,20-diphenyl, is an important aspect and might play a differentiating part with regard to the photodynamic therapy efficiency of this type of photosensitizers across distinct tumor cells. The chick embryo has long been used as a prototypical organism in several research areas, including oncobiology,[55] although studies on photodynamic therapy are scarce.[53,54] It is surrounded by the CAM, a highly vascularized extra-embryonic membrane that can effortlessly be used to graft human cells. When implanted on the CAM, tumor cells are capable of stimulating the formation of new blood vessels, gaining their blood supply, which in turn allows them to develop in a related fashion as in their natural hosts, that is, to proliferate, invade, and metastasize to the chick embryonic organs. This presents several key advantages over other standard animal models: the chick embryo is naturally immunodeficient, thus easily allowing mammalian tissue xenografts; the procedures are relatively simple, involving short experimental times and low costs. Also, regarding the protection of animals used for scientific purposes, the use of nonmammal embryos does not encompass any legal or ethical restrictions.[55−57] In a previous study, we demonstrated that chlorins 3 and 4 show a melanoma A375 cell uptake significantly higher than the ones observed for the corresponding diester derivatives 1 and 2.[40] On the other hand, in vitro data showed some decrease in the metabolic activity of both A375 skin malignant melanoma and HFF-1 fibroblast cells after exposure to chlorin 4. Thus, dihydroxymethyl chlorin 3 showing no dark in vitro cytotoxicity was selected for the in vivo chick embryo CAM assessment of a human OE19 esophageal adenocarcinoma model. The schematic protocol and timeline for this study is presented in Figure .
Figure 3

Schematic illustration and timeline for the in vivo chick embryo CAM assay (replicated with permission from Inovotion SAS, La Tronche/Grenoble, France).

Schematic illustration and timeline for the in vivo chick embryo CAM assay (replicated with permission from Inovotion SAS, La Tronche/Grenoble, France). After nine days of incubation (E9), when the embryo has reached adequate development, the chorioallantoic membrane of White Leghorn chicken eggs was grafted with OE19 cells. At day 11 (E11), all groups of eggs were treated with either the administration vehicle (1% DMSO in PBS, groups I and III) or chlorin 3 (608 nM, groups II and IV). Ten minutes after administration, eggs of groups III and IV were subjected to light irradiation using the conditions indicated in the Supporting Information (see Table S1). The number of dead and alive chick embryos was fully counted at E18 and combined with the surveillance of visible and macroscopic anomalies (see Table S2); the key data are displayed in Figure . Interestingly, we observed an ∼50% chick embryo mortality rate in both light-exposed groups III and IV, but none whatsoever when only chlorin 3 was administered in group II (15% compared to 29% in the control group). This is a highly relevant outcome of the toxicity assay performed because it markedly demonstrates that the chick embryo mortality attained in the PDT group is mainly due to the illumination conditions applied.
Figure 4

In vivo chick embryo CAM assay toxicity analysis, presenting the total, alive, and dead chick embryos for each group of eggs after treatment at E18.

In vivo chick embryo CAM assay toxicity analysis, presenting the total, alive, and dead chick embryos for each group of eggs after treatment at E18. At day 18 (E18) of the in vivo chick embryo CAM assay, the CAM was collected and analyzed (see Figure . As can be seen in Table S3 and Figure , no substantial tumor weight variation compared to the control group was observed in groups II and III, which means that neither ring-fused chlorin 3 nor light irradiation per se produced a cytotoxic outcome on OE19 cells. However, the combination of the two, group IV, that is, the PDT treatment group, prompted a substantial photodynamic effect with a tumor weight regression of 33% reached with a single-treatment protocol with the photosensitizer dose as low as 37 ng/embryo.
Figure 5

In vivo chick embryo CAM assay tumor growth analysis, presenting mean values ± SEM of tumor weights (mg) for each group of eggs after treatment. The upper portion of the CAM was detached at E18, and the tumors were carefully removed from normal tissue and weighed. Significant differences are represented by * where * means p < 0.05.

In vivo chick embryo CAM assay tumor growth analysis, presenting mean values ± SEM of tumor weights (mg) for each group of eggs after treatment. The upper portion of the CAM was detached at E18, and the tumors were carefully removed from normal tissue and weighed. Significant differences are represented by * where * means p < 0.05. Genomic DNA was extracted from the CAM and analyzed by quantitative polymerase chain reaction (qPCR) with specific primers for Alu sequences. Since these are primate-specific short interspersed elements (SINEs) with over 1 million copies of which are present in the human genome, Alu sequences are useful targets for detecting human cells.[58,59] From the information exhibited in Figure , it was possible to infer that no consequence, either beneficial or detrimental, was verified in any of the treatment groups under scrutiny, that is, the application of chlorin 3 or light irradiation on its own and the PDT group, given that the fold variation of the relative amount of metastasis (RQ value) compared to the control group/calibrator (which was arbitrarily set to 1) was only ±0.3 at the most. This value is less than the 2-fold change (RQ value greater than 2 or minor than 0.5) typically required to be considered significative.[60,61] Regarding the mean cycle quantification (mean Cq) values attained, it stands to reason that the number of cycles needed for a fluorescence signal to be detected was quite nearly the same in all samples studied, between 25.41 and 26.28, regardless of the treatment groups and conditions (see Table S4). Therefore, our study demonstrated that a nanomolar dose is enough to observe a PDT effect in the tumor at the upper CAM without an antimetastatic effect in the lower CAM.
Figure 6

In vivo chick embryo CAM assay metastasis invasion analysis, presenting relative amounts of metastasis in the lower CAM for each group of eggs after treatment compared to the control group (in which an arbitrary value of 1 was chosen). The effect on the metastatic invasion of the OE19 cells was evaluated in a portion of the lower CAM collected at E18. No significant differences were found between groups.

In vivo chick embryo CAM assay metastasis invasion analysis, presenting relative amounts of metastasis in the lower CAM for each group of eggs after treatment compared to the control group (in which an arbitrary value of 1 was chosen). The effect on the metastatic invasion of the OE19 cells was evaluated in a portion of the lower CAM collected at E18. No significant differences were found between groups.

Conclusions

In conclusion, the photocytotoxicity of 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine-fused 10,20-diphenylchlorins and 5,15-diphenylchlorins against human HT1376 urinary bladder carcinoma and OE19 esophageal adenocarcinoma cell lines was examined, and IC50 values of 12.8–43.0 and 12.9–26.6 nM, respectively, were obtained. All molecules proved to be extraordinarily potent low-dose PSs. Furthermore, structure–activity relationships could be identified. The diphenyl substitution pattern of the macrocycle, 5,15-diphenylchlorins versus 10,20-diphenyl, is the structural feature with higher impact on the modulation of the PDT activity, although the overall hydrophilicity/hydrophobicity of the diphenylchlorin scaffold must also be considered. In fact, the diester as well as the dihydroxymethyl 5,15-diphenylchlorin derivatives presented a slightly superior photodynamic action against both cell lines to their corresponding isomeric 10,20-diphenylchlorins. Dihydroxymethyl 5,15-diphenylchlorin was chosen for the in vivo evaluation using an OE19 tumor/chick embryo CAM model. Despite their high photodynamic activity, this photosensitizer did not show cytotoxicity per se since the chick embryo survival rate was very high (85%) when the chlorin was applied without photoactivation. On the other hand, no significant tumor weight variation was observed when the chlorin or light irradiation was employed per se. Therefore, it was only under the photodynamic treatment conditions that phototoxicity was observed leading to a considerable tumor weight regression of 33% in a single-PDT treatment while using a very low dose in the range of tens of nanograms per embryo.

Experimental Section

Chlorins were prepared from the reaction of 2,2-dioxo-1H,3H-pyrazolo[1,5-c][1,3]thiazole-6,7-dicarboxylate and 5,15-diphenylporphyrin under microwave irradiation as previously described.[39]

In Vitro Tumor Cell Biology Assay

Cell Culture Conditions

The human HT1376 (CRL1472) urinary bladder carcinoma cell line was purchased from the American Type Culture Collection. The human OE19 (96071721) esophageal adenocarcinoma cell line was purchased from the European Collection of Authenticated Cell Cultures. The cell lines were cultured according to standard procedures at 37 °C in a humidified incubator with 95% air and 5% CO2. HT1376 cells were expanded using the Dulbecco’s Modified Eagle Medium (DMEM, Sigma D-5648), supplemented with 10% heat-inactivated fetal bovine serum (FBS, Sigma F7524), 1% penicillinstreptomycin (100 U/mL penicillin and 10 mg/mL streptomycin, Gibco 15140-122), and 100 μM sodium pyruvate (Gibco Invitrogen Life Technologies; Gibco 1360). OE19 cells were expanded using the Roswell Park Memorial Institute 1640 medium (RPMI 1640, Sigma R4130), supplemented with 10% heat-inactivated fetal bovine serum (FBS, Sigma F7524), 1% penicillinstreptomycin (100 U/mL penicillin and 10 mg/mL streptomycin, Gibco 15140-122), and 400 mM sodium pyruvate (Gibco Invitrogen Life Technologies; Gibco 1360). For all studies, cells were detached using a solution of 0.25% trypsin–EDTA (Gibco).

Photodynamic Treatment

For each experiment, cells were plated and kept in an incubator overnight to allow the attachment of the cells. The formulation of the chlorin photosensitizers consisted of a 1 mg/mL solution in DMSO (Fisher Chemical, 200-664-3) with the desired concentrations achieved by successive dilutions. Photosensitizers were administered in several concentrations (from 5 pM to 10 μM), and cells were incubated for 24 h. Controls were included on every plate, including untreated cell cultures and cultures treated only with the vehicle of administration of the photosensitizers. For this, DMSO was always administered with a concentration of 1%. Cells were washed with phosphate buffered saline (PBS; in mM: 137 NaCl (JMGS), 2.7 KCl (Sigma), 10 Na2HPO4 (Merck), and 1.8 KH2PO4 (Sigma); pH 7.4), and a new drug-free medium was added. Each plate was irradiated with a fluence rate of 7.5 mW/cm2 until a total of 10 J was reached using a light source equipped with a red filter (cutoff of <560 nm). Evaluation was performed 24 h after photodynamic treatment.

Photocytotoxicity Analysis

The sensitivity of the cell lines to the chlorin photosensitizers was analyzed using the MTT colorimetric assay (Sigma M2128; Sigma-Aldrich, Inc.) to measure metabolic activity. Cell culture plates were washed and incubated with a solution of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (0.5 mg/mL, Sigma M5655) in PBS, pH 7.4, in the dark at 37 °C for at least 4 h. To solubilize formazan crystals, a 0.04 M solution of hydrochloric acid (Merck Millipore100317) in isopropanol (Sigma 278475) was added. Absorbance was measured using an EnSpire Multimode Plate Reader (Perkin Elmer). Photocytotoxicity was expressed as the percentage relative to cell cultures treated only with the vehicle of administration of the photosensitizers. Dose–response curves were obtained using Origin 9.0, and the concentration of the photosensitizers that inhibits the proliferation of cultures at 50% (IC50) was derived.

In Vivo Chick Embryo CAM Assay

Materials

Fertilized White Leghorn chicken eggs (Hendrix Genetics, Saint Brieuc, France) were incubated at 37.5 °C with 50% relative humidity for nine days. At this time (E9), the chorioallantoic membrane (CAM) was dropped down by carefully drilling a small hole through the eggshell into the air sac, and a 1 cm2 window was cut in the eggshell directly above the CAM.

Tumor Cell Induction

Human OE19 esophageal adenocarcinoma cells were cultured and expanded as described above, harvested by trypsinization, washed with complete medium, and suspended in a serum-free graft medium. An inoculation of 5 × 105 cells onto the CAM of each egg was made at day 9 (E9). The eggs were then randomly allocated into 4 groups with at least 20 eggs/group.

Treatment

At day 10 (E10), tumors began to be detectable. At day 11 (E11), the groups were treated with 100 μL of chlorin 3 (608 nM) or the administration vehicle (1% DMSO in PBS), following the conditions summarized in the Supporting Information (see Table S1). Ten minutes after injection in the tumor mass, eggs of groups III and IV were placed under the light source (a CoolLED pE-4000 universal illumination system equipped with a collimator, see Figure S1) for irradiation using red light (635 nm) with a fluence of 2.5 J/cm2. The light source with a collimator was previously calibrated on eggs grafted with OE19 cells at day 11 (E11) using white light in order to achieve efficient illumination closely around the treated area, that is, centered on the tumor (see Figure S2, top). The distance between the surface of the upper CAM and the light source with the collimator was 26 cm, and the diameter of the circle illuminated in the upper CAM was 2.5 cm (see Figure S2, bottom). The time of irradiation needed to reach 2.5 J/cm2 was 1 min at 83 mW.

Tumor Growth Analysis

At day 18 (E18), the upper portion of the CAM was removed, washed with PBS and then directly transferred in 4% p-formaldehyde solution (fixation for 48 h). The tumors were then carefully cut away from normal CAM tissue and weighed. A one-way ANOVA analysis with post-hoc tests was then performed on the data (see Table S3).

Metastasis Invasion Analysis

A 1 cm2 portion of the lower CAM was collected to evaluate the number of metastasis cells. Genomic DNA was extracted from the CAM using a commercial kit (MagJET Genomic DNA Kit, Ref. K2721, Thermo Scientific) and analyzed by quantitative polymerase chain reaction (qPCR) with specific primers for human Alu sequences (sense: 5′-ACG CCT GTA ATC CCA GCA CTT-3′; antisense: 5′-TCG CCC AGG CTG GAG TGCA-3′). The amplification and detection of these Alu sequences by qPCR was performed on 30 ng of genomic DNA in a final volume of 20 μL/point using a Bio-Rad CFX96 Touch detection system with the following conditions: 95 °C for 2 min followed by 35 cycles at 95 °C for 30 s, 63 °C for 30 s, and 72 °C for 30 s. The variation in the Alu signal relative to the total amount of genomic DNA (and, therefore, changes in the quantity of human DNA in the CAM tissue) as well as statistical analysis on the data obtained was calculated using Bio-Rad CFX Maestro software (see Table S4).

Toxicity Analysis

The number of dead and alive chick embryos was totally counted seven days after treatment (E18) and combined with the observation of visible and macroscopic abnormalities (see Table S2).
  53 in total

1.  A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reaction.

Authors:  Andries Zijlstra; Rebecca Mellor; Giano Panzarella; Ronald T Aimes; John D Hooper; Natalia D Marchenko; James P Quigley
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

2.  Photosensitizer Radachlorin®: Skin cancer PDT phase II clinical trials.

Authors:  Elena V Kochneva; Elena V Filonenko; Elena G Vakulovskaya; Elena G Scherbakova; Oleg V Seliverstov; Nikolay A Markichev; Andrei V Reshetnickov
Journal:  Photodiagnosis Photodyn Ther       Date:  2010-08-14       Impact factor: 3.631

3.  Individualized, multimodal palliative treatment of inoperable esophageal cancer: clinical impact of photodynamic therapy resulting in prolonged survival.

Authors:  Joerg Lindenmann; Veronika Matzi; Nicole Neuboeck; Udo Anegg; Eva Baumgartner; Alfred Maier; Josef Smolle; Freyja Maria Smolle-Juettner
Journal:  Lasers Surg Med       Date:  2012-02-14       Impact factor: 4.025

4.  Real-time, in vivo measurement of tissular pO2 through the delayed fluorescence of endogenous protoporphyrin IX during photodynamic therapy.

Authors:  Filippo Piffaretti; Anna Maria Novello; Rajendran Senthil Kumar; Eddy Forte; Cédric Paulou; Patrycja Nowak-Sliwinska; Hubert van den Bergh; Georges Wagnières
Journal:  J Biomed Opt       Date:  2012-11       Impact factor: 3.170

5.  The effect of Radachlorin® PDT in advanced NSCLC: a pilot study.

Authors:  Wonjun Ji; Jung-wan Yoo; Eun Kyung Bae; Ji Hye Lee; Chang-Min Choi
Journal:  Photodiagnosis Photodyn Ther       Date:  2013-03-16       Impact factor: 3.631

Review 6.  Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.

Authors:  Demian van Straten; Vida Mashayekhi; Henriette S de Bruijn; Sabrina Oliveira; Dominic J Robinson
Journal:  Cancers (Basel)       Date:  2017-02-18       Impact factor: 6.639

7.  Chick embryo chorioallantoic membrane (CAM): an alternative predictive model in acute toxicological studies for anti-cancer drugs.

Authors:  Chin Siang Kue; Kae Yi Tan; May Lynn Lam; Hong Boon Lee
Journal:  Exp Anim       Date:  2015-01-22

8.  Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer.

Authors:  M T Huggett; M Jermyn; A Gillams; R Illing; S Mosse; M Novelli; E Kent; S G Bown; T Hasan; B W Pogue; S P Pereira
Journal:  Br J Cancer       Date:  2014-02-25       Impact factor: 7.640

9.  Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization.

Authors:  Andrea Weiss; Judy R van Beijnum; Debora Bonvin; Patrice Jichlinski; Paul J Dyson; Arjan W Griffioen; Patrycja Nowak-Sliwinska
Journal:  J Cell Mol Med       Date:  2014-01-22       Impact factor: 5.310

10.  Immunogenic cell death due to a new photodynamic therapy (PDT) with glycoconjugated chlorin (G-chlorin).

Authors:  Mamoru Tanaka; Hiromi Kataoka; Shigenobu Yano; Takuya Sawada; Haruo Akashi; Masahiro Inoue; Shugo Suzuki; Yusuke Inagaki; Noriyuki Hayashi; Hirotada Nishie; Takaya Shimura; Tsutomu Mizoshita; Yoshinori Mori; Eiji Kubota; Satoshi Tanida; Satoru Takahashi; Takashi Joh
Journal:  Oncotarget       Date:  2016-07-26
View more
  4 in total

Review 1.  Applications of Photodynamic Therapy in Endometrial Diseases.

Authors:  Gabriela Correia-Barros; Beatriz Serambeque; Maria João Carvalho; Carlos Miguel Marto; Marta Pineiro; Teresa M V D Pinho E Melo; Maria Filomena Botelho; Mafalda Laranjo
Journal:  Bioengineering (Basel)       Date:  2022-05-23

2.  Ring-Fused meso-Tetraarylchlorins as Auspicious PDT Sensitizers: Synthesis, Structural Characterization, Photophysics, and Biological Evaluation.

Authors:  Mafalda Laranjo; Nelson A M Pereira; Andreia S R Oliveira; Márcia Campos Aguiar; Gonçalo Brites; Bruno F O Nascimento; Beatriz Serambeque; Bruna D P Costa; João Pina; J Sérgio Seixas de Melo; Marta Pineiro; M Filomena Botelho; Teresa M V D Pinho E Melo
Journal:  Front Chem       Date:  2022-04-27       Impact factor: 5.545

3.  First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds.

Authors:  Béla Ózsvári; Federica Sotgia; Michael P Lisanti
Journal:  Aging (Albany NY)       Date:  2020-05-24       Impact factor: 5.682

4.  Novel fluorinated ring-fused chlorins as promising PDT agents against melanoma and esophagus cancer.

Authors:  Nelson A M Pereira; Mafalda Laranjo; Bruno F O Nascimento; João C S Simões; João Pina; Bruna D P Costa; Gonçalo Brites; João Braz; J Sérgio Seixas de Melo; Marta Pineiro; Maria Filomena Botelho; Teresa M V D Pinho E Melo
Journal:  RSC Med Chem       Date:  2021-04-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.